• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR/Cas9介导的基因校正可逆转分化的小脑神经元中与脊髓小脑共济失调3相关的疾病表型。

CRISPR/Cas9-mediated genetic correction reverses spinocerebellar ataxia 3 disease-associated phenotypes in differentiated cerebellar neurons.

作者信息

Song Guoxu, Ma Yuying, Gao Xing, Zhang Xuewen, Zhang Fei, Tian Chunhong, Hou Jiajia, Liu Zheng, Zhao Zixin, Tian Yong

机构信息

Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.

University of Chinese Academy of Sciences, Beijing 100049, China.

出版信息

Life Med. 2022 Jun 29;1(1):27-44. doi: 10.1093/lifemedi/lnac020. eCollection 2022 Aug.

DOI:10.1093/lifemedi/lnac020
PMID:39872157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11749335/
Abstract

The neurodegenerative disease spinocerebellar ataxia type 3 (SCA3; also called Machado-Joseph disease, MJD) is a trinucleotide repeat disorder caused by expansion of the CAG repeats in the gene. Here, we applied a CRISPR/Cas9-mediated approach using homologous recombination to achieve a one-step genetic correction in SCA3-specific induced pluripotent stem cells (iPSCs). The genetic correction reversed disease-associated phenotypes during cerebellar region-specific differentiation. In addition, we observed spontaneous ataxin-3 aggregates specifically in mature cerebellar neurons differentiated from SCA3 iPSCs rather than in SCA3 pan-neurons, SCA3 iPSCs or neural stem cells, suggesting that SCA3 iPSC-derived disease-specific and region-specific cerebellar neurons can provide unique cellular models for studying SCA3 pathogenesis . Importantly, the genetically corrected cerebellar neurons did not display typical SCA3 aggregates, suggesting that genetic correction can subsequently reverse SCA3 disease progression. Our strategy can be applied to other trinucleotide repeat disorders to facilitate disease modeling, mechanistic studies and drug discovery.

摘要

神经退行性疾病3型脊髓小脑共济失调(SCA3;也称为马查多-约瑟夫病,MJD)是一种由该基因中CAG重复序列扩增引起的三核苷酸重复序列疾病。在此,我们应用了一种基于同源重组的CRISPR/Cas9介导方法,在SCA3特异性诱导多能干细胞(iPSC)中实现一步基因校正。这种基因校正逆转了小脑区域特异性分化过程中与疾病相关的表型。此外,我们观察到ataxin-3聚集体自发地特异性出现在由SCA3 iPSC分化而来的成熟小脑神经元中,而非SCA3全神经元、SCA3 iPSC或神经干细胞中,这表明SCA3 iPSC来源的疾病特异性和区域特异性小脑神经元可为研究SCA3发病机制提供独特的细胞模型。重要的是,经基因校正的小脑神经元未显示出典型的SCA3聚集体,这表明基因校正随后可逆转SCA3疾病进展。我们的策略可应用于其他三核苷酸重复序列疾病,以促进疾病建模、机制研究和药物发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/79cf52697e02/lnac020_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/c7f7763ebc3c/lnac020_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/29db6f41a089/lnac020_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/1c6c2da3f8e1/lnac020_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/c244e7838b32/lnac020_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/5fdb06f6e595/lnac020_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/b69749a1ded2/lnac020_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/79cf52697e02/lnac020_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/c7f7763ebc3c/lnac020_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/29db6f41a089/lnac020_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/1c6c2da3f8e1/lnac020_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/c244e7838b32/lnac020_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/5fdb06f6e595/lnac020_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/b69749a1ded2/lnac020_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf9e/11749335/79cf52697e02/lnac020_fig7.jpg

相似文献

1
CRISPR/Cas9-mediated genetic correction reverses spinocerebellar ataxia 3 disease-associated phenotypes in differentiated cerebellar neurons.CRISPR/Cas9介导的基因校正可逆转分化的小脑神经元中与脊髓小脑共济失调3相关的疾病表型。
Life Med. 2022 Jun 29;1(1):27-44. doi: 10.1093/lifemedi/lnac020. eCollection 2022 Aug.
2
CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells.CRISPR/Cas9 介导的基因纠正改善了小脑共济失调 3 型患者诱导多能干细胞中的异常表型。
Transl Psychiatry. 2021 Sep 17;11(1):479. doi: 10.1038/s41398-021-01605-2.
3
CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.CRISPR/Cas9 靶向敲除小脑共济失调 3 型诱导多能干细胞中的多聚谷氨酰胺。
Stem Cells Dev. 2018 Jun 1;27(11):756-770. doi: 10.1089/scd.2017.0209. Epub 2018 May 18.
4
Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.中国家系遗传性脊髓小脑共济失调患者中SCA1、SCA2、SCA3/MJD、SCA6、SCA7和DRPLA CAG三核苷酸重复扩增的频率
Arch Neurol. 2000 Apr;57(4):540-4. doi: 10.1001/archneur.57.4.540.
5
A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.一个新的人源化 ataxin-3 敲入小鼠模型结合了 SCA3/MJD 的遗传特征、神经元和神经胶质的发病机制以及疾病的晚期发病。
Neurobiol Dis. 2015 Jan;73:174-88. doi: 10.1016/j.nbd.2014.09.020. Epub 2014 Oct 7.
6
Genome editing in spinocerebellar ataxia type 3 cells improves Golgi apparatus structure.对3型脊髓小脑共济失调细胞进行基因组编辑可改善高尔基体结构。
Sci Rep. 2025 Apr 9;15(1):12106. doi: 10.1038/s41598-025-93369-8.
7
Preimplantation Genetic Testing of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease-Robust Tools for Direct and Indirect Detection of the (CAG) Repeat Expansion.脊髓小脑性共济失调 3 型/马查多-约瑟夫病的植入前遗传学检测——直接和间接检测 (CAG) 重复扩增的强大工具。
Int J Mol Sci. 2024 Jul 24;25(15):8073. doi: 10.3390/ijms25158073.
8
Machado Joseph-Disease Is Rare in the Peruvian Population.马查多-约瑟夫病在秘鲁人群中罕见。
Cerebellum. 2023 Dec;22(6):1192-1199. doi: 10.1007/s12311-022-01491-4. Epub 2022 Nov 3.
9
Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells.自噬促进神经分化的脊髓小脑共济失调3型人类诱导多能干细胞中突变型ATXN3的降解。
Biomed Res Int. 2016;2016:6701793. doi: 10.1155/2016/6701793. Epub 2016 Oct 25.
10
Generation of an induced pluripotent stem cell line from a patient with spinocerebellar ataxia type 3 (SCA3): HIHCNi002-A.从一名3型脊髓小脑共济失调(SCA3)患者中生成诱导多能干细胞系:HIHCNi002-A。
Stem Cell Res. 2018 Jul;30:171-174. doi: 10.1016/j.scr.2018.06.006. Epub 2018 Jun 11.

引用本文的文献

1
Identification of regulatory sequences in Aca11 and Aca13 for detection of anti-CRISPR and protein-protein interaction.鉴定Aca11和Aca13中的调控序列以检测抗CRISPR和蛋白质-蛋白质相互作用。
Nucleic Acids Res. 2025 Jul 19;53(14). doi: 10.1093/nar/gkaf694.
2
Genetic enhancement: an avenue to combat aging-related diseases.基因增强:对抗衰老相关疾病的一条途径。
Life Med. 2022 Nov 22;1(3):307-318. doi: 10.1093/lifemedi/lnac054. eCollection 2022 Dec.

本文引用的文献

1
Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing.发现了强效且多功能的 CRISPR-Cas9 抑制剂,这些抑制剂经过工程设计,可用于化学可控的基因组编辑。
Nucleic Acids Res. 2022 Mar 21;50(5):2836-2853. doi: 10.1093/nar/gkac099.
2
Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing.利用双模板 Prime 编辑技术实现大片段 DNA 序列的可编程删除、替换、插入和倒位。
Nat Biotechnol. 2022 May;40(5):731-740. doi: 10.1038/s41587-021-01133-w. Epub 2021 Dec 9.
3
CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells.
CRISPR/Cas9 介导的基因纠正改善了小脑共济失调 3 型患者诱导多能干细胞中的异常表型。
Transl Psychiatry. 2021 Sep 17;11(1):479. doi: 10.1038/s41398-021-01605-2.
4
AcrIIA5 Inhibits a Broad Range of Cas9 Orthologs by Preventing DNA Target Cleavage.AcrIIA5 通过阻止 DNA 靶标切割来抑制广泛的 Cas9 同源物。
Cell Rep. 2019 Nov 26;29(9):2579-2589.e4. doi: 10.1016/j.celrep.2019.10.078.
5
Search-and-replace genome editing without double-strand breaks or donor DNA.无双链断裂或供体 DNA 的搜索和替换基因组编辑。
Nature. 2019 Dec;576(7785):149-157. doi: 10.1038/s41586-019-1711-4. Epub 2019 Oct 21.
6
Anti-CRISPRs: The natural inhibitors for CRISPR-Cas systems.抗CRISPR蛋白:CRISPR-Cas系统的天然抑制剂
Animal Model Exp Med. 2019 May 29;2(2):69-75. doi: 10.1002/ame2.12069. eCollection 2019 Jun.
7
CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.CRISPR/Cas9 靶向敲除小脑共济失调 3 型诱导多能干细胞中的多聚谷氨酰胺。
Stem Cells Dev. 2018 Jun 1;27(11):756-770. doi: 10.1089/scd.2017.0209. Epub 2018 May 18.
8
Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells.通过CRISPR/Cas9介导的基因校正逆转亨廷顿病患者来源的诱导多能干细胞中的表型异常
Stem Cell Reports. 2017 Mar 14;8(3):619-633. doi: 10.1016/j.stemcr.2017.01.022. Epub 2017 Feb 23.
9
The Machado-Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53.马查多-约瑟夫病去泛素化酶ataxin-3调节p53的稳定性和凋亡功能。
PLoS Biol. 2016 Nov 16;14(11):e2000733. doi: 10.1371/journal.pbio.2000733. eCollection 2016 Nov.
10
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells.CRISPR/Cas9对人类造血干细胞β-珠蛋白基因的靶向作用。
Nature. 2016 Nov 17;539(7629):384-389. doi: 10.1038/nature20134. Epub 2016 Nov 7.